Inflammation and mortality in a frail mouse model
Open Access
- 2 June 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in AGE
- Vol. 34 (3), 705-715
- https://doi.org/10.1007/s11357-011-9269-6
Abstract
Mice homozygous for targeted deletion of the interleukin 10 gene (Il-10) have been partially characterized as a model for human frailty. These mice have increased serum interleukin (IL)-6 in midlife, skeletal muscle weakness, and an altered skeletal muscle gene expression profile compared to age and sex-matched C57BL/6 (B6) control mice. In order to further characterize for use as a frailty model, we evaluated the evolution of inflammatory pathway activation, endocrine change, and mortality in these mice. Serum was collected in groups of age- and sex-matched B6.129P2-Il10 tm1Cgn /J (IL-10tm/tm) mice and B6 control mice at age 12, 24, 48, 72, and 90 weeks. Cytokines including IL-6, interleukin 1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), chemokine (C-X-C motif) ligand 1 (KC), IL-12, and IL-10 were measured using electro-chemiluminescent multiplex immunoassay and insulin-like growth factor 1 (IGF-1) was measured using solid-phase enzyme-linked immunosorbent assay. A separate longitudinal cohort was monitored from age 35 weeks to approximately 100 weeks. Survival was evaluated by Kaplan–Meier survival estimates and detailed necropsy information was gathered in a subset of mice that died or were sacrificed. In IL-10tm/tm mice compared to B6 controls, serum IL-6, IL-1β, TNF-α, IFN-γ, KC levels were significantly elevated across the age groups, serum mean IGF-1 levels were higher in the 48-week-old groups, and overall mortality rate was significantly higher. The quadratic relationship between IGF-1 and age was significantly different between the two strains of mice. Serum IL-6 was positively associated with IGF-1 but the effect was significantly larger in IL-10tm/tm mice. These findings provide additional rationale for the use of the IL-10tm/tm mouse as a model for frailty and for low-grade inflammatory pathway activation.Keywords
This publication has 40 references indexed in Scilit:
- Inflammation and Immune System Alterations in FrailtyClinics in Geriatric Medicine, 2011
- Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levelsAging Cell, 2009
- Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exerciseJournal of Applied Physiology, 2009
- Can We Develop Genetically Tractable Models to Assess Healthspan (Rather Than Life Span) in Animal Models?The Journals of Gerontology: Series A, 2009
- Stimulus-response paradigm for characterizing the loss of resilience in homeostatic regulation associated with frailtyMechanisms of Ageing and Development, 2008
- Protein hormones and immunityBrain, Behavior, and Immunity, 2007
- Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older AdultsJournal of the American Geriatrics Society, 2006
- Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO miceExperimental Gerontology, 2005
- From hormones to immunity: the physiology of immunologyBrain, Behavior, and Immunity, 2004
- Interleukin-10 gene knock-out mice: a model of chronic inflammationClinical Immunology and Immunopathology, 1995